We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$878M
AUM Growth
+$263M
Cap. Flow
+$202M
Cap. Flow %
23.06%
Top 10 Hldgs %
66.52%
Holding
99
New
19
Increased
53
Reduced
17
Closed
9

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$49M
2
KO icon
Coca-Cola
KO
+$18.9M
3
XOM icon
ExxonMobil
XOM
+$14.7M
4
PG icon
Procter & Gamble
PG
+$10.2M
5
VFC icon
VF Corp
VFC
+$7.64M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$4.24M
2
RTN
Raytheon Company
RTN
+$2.59M
3
UNH icon
UnitedHealth
UNH
+$1.84M
4
LHX icon
L3Harris
LHX
+$1.79M
5
MCK icon
McKesson
MCK
+$1.67M

Sector Composition

Rank Sector Weight
1 Consumer Staples 46.25%
2 Healthcare 16.85%
3 Energy 10.84%
4 Industrials 6.15%
5 Financials 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
51
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.31M 0.26%
16,750
+2,535
+18% +$338K
PX
52
DELISTED
Praxair Inc
PX
$2.29M 0.26%
17,780
+4,610
+35% +$605K
LLY icon
53
Eli Lilly
LLY
$1.07T
$2.15M 0.25%
33,200
-8,000
-19% -$507K
BF.B icon
54
Brown-Forman Class B
BF.B
$12.6B
$2.12M 0.24%
+73,475
New +$2.16M
EBAY icon
55
eBay
EBAY
$50.3B
$2.11M 0.24%
88,539
+26,525
+43% +$590K
CSX icon
56
CSX Corp
CSX
$96B
$2.06M 0.23%
192,477
+110,805
+136% +$1.14M
ADSK icon
57
Autodesk
ADSK
$47.7B
$2.02M 0.23%
36,700
+23,800
+184% +$1.3M
CLX icon
58
Clorox
CLX
$11.8B
$1.92M 0.22%
19,945
+4,690
+31% +$424K
DVN icon
59
Devon Energy
DVN
$49.8B
$1.9M 0.22%
27,940
+7,440
+36% +$553K
HAL icon
60
Halliburton
HAL
$26.8B
$1.88M 0.21%
+29,100
New +$2M
NSC icon
61
Norfolk Southern
NSC
$77.1B
$1.82M 0.21%
16,307
-11,277
-41% -$1.2M
DD
62
DELISTED
Du Pont De Nemours E I
DD
$1.8M 0.21%
26,499
-5,828
-18% -$367K
UBS icon
63
UBS Group
UBS
$172B
$1.74M 0.2%
+100,000
New +$1.78M
FITB
64
Fifth Third Bancorp
FITB
$51.7B
$1.62M 0.18%
80,840
+33,531
+71% +$688K
ADBE icon
65
Adobe
ADBE
$94.5B
$1.6M 0.18%
+23,200
New +$1.64M
GSK icon
66
GSK
GSK
$104B
$1.56M 0.18%
+27,097
New +$1.66M
CB icon
67
Chubb
CB
$139B
$1.46M 0.17%
+13,900
New +$1.45M
XLNX
68
DELISTED
Xilinx Inc
XLNX
$1.45M 0.17%
34,350
-20,950
-38% -$915K
CI icon
69
Cigna
CI
$77B
$1.42M 0.16%
15,700
-3,900
-20% -$364K
WBA
70
DELISTED
Walgreens Boots Alliance
WBA
$1.39M 0.16%
23,440
+12,940
+123% +$849K
MSS
71
DELISTED
MILESTONE SCIENTIFIC INC (NEW)
MSS
$1.13M 0.13%
+32,780
New +$1.13M
BAC icon
72
Bank of America
BAC
$436B
$1.09M 0.12%
64,250
-18,819
-23% -$300K
ALL icon
73
Allstate
ALL
$67.3B
$1.07M 0.12%
+17,426
New +$1.05M
MRSH
74
Marsh
MRSH
$87.5B
$1.05M 0.12%
20,000
DD icon
75
DuPont de Nemours
DD
$18.9B
$941K 0.11%
7,092
+497
+8% +$66.3K

Similar funds

Cullinan Associates's Q3 2014 Portfolio in Review

As of Q3 2014, Cullinan Associates held 99 positions worth $878M, up 43% from $615M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cullinan Associates deployed $202M of net new capital in Q3 2014, opening 19 new positions and adding to 53 existing holdings. Its largest new stake was VF Corp: 127,785 shares worth $7.95M.

By sector, the portfolio is most concentrated in Consumer Staples at 46% of assets, down from 56% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Microsoft, an estimated $4.24M trimmed.

  • Cullinan Associates's largest Q3 2014 buy was VF Corp: 127,785 shares worth $7.95M.
  • Cullinan Associates added most to Bristol-Myers Squibb in Q3 2014, an estimated $49M increase.
  • Cullinan Associates's biggest Q3 2014 reduction was Microsoft, cutting an estimated $4.24M.
  • Cullinan Associates fully exited Raytheon Company in Q3 2014, selling an estimated $2.59M.
  • Cullinan Associates's ten largest holdings make up 67% of its $878M portfolio in Q3 2014.
  • Cullinan Associates opened 19 new positions and closed 9 in Q3 2014.
  • Cullinan Associates's portfolio value rose 43% quarter-over-quarter to $878M.

Based on Cullinan Associates's 13F filing for Q3 2014, filed 12 Nov 2014.